Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA “Available Therapy” Determination Is A Moving Target, Industry Groups Say

Sep 02 2013

• By Sue Sutter

Related Content

Redefining Accelerated Approval Criteria Would Expand Pathway’s Use, Panel Says

Nov 26 2012

<em>Xarelto</em> Tested FDA’s Comparative Efficacy Powers, But Conservative View Prevailed

May 01 2012

FDA Accelerated Approval For Rare Diseases Again Under Congressional Pressure

Jul 30 2013

FDA Flexible With Accelerated Approval Evidence, Analysis Finds

Sep 02 2013

Related Companies

Bayer AG

Johnson & Johnson

Boehringer Ingelheim GmbH

Genentech, Inc.

Additional Topics

United States Drug Approval Standards BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window